Cycloplegic Delivery Investigation

This study has been completed.
Sponsor:
Information provided by:
Ohio State University
ClinicalTrials.gov Identifier:
NCT00472524
First received: May 9, 2007
Last updated: July 1, 2008
Last verified: July 2008
  Purpose

The goal of this study is to compare the effectiveness of the administration of sequential drops, a combination drop and a combination spray for producing mydriasis and cycloplegia.


Condition Intervention
Healthy
Procedure: Mydriasis/cycloplegia via different modes of administration

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Further study details as provided by Ohio State University:

Estimated Enrollment: 50
  Eligibility

Ages Eligible for Study:   8 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients ages 8 to 30 with best corrected acuity of 20/30 or better in both eyes at distance and near will be recruited.

Exclusion Criteria:

  • vision not correctable to 20/30 or better
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472524

Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472524     History of Changes
Other Study ID Numbers: 2003H0072
Study First Received: May 9, 2007
Last Updated: July 1, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 24, 2014